Laurence Chapuy1, Marwa Bsat1, Manuel Rubio1, François Harvey2, Vinicius Motta3, Frank Schwenter4, Ramses Wassef4, Carole Richard4, Colette Deslandres5, Bich N Nguyen6, Geneviève Soucy6, Nir Hacohen7, Jorge Fritz8, Alexandra-Chloé Villani7,9, Heena Mehta1, Marika Sarfati1. 1. Immunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal [CRCHUM], Montréal, QC, Canada. 2. Department of Biomedical Informatics, Centre de Recherche du Centre Hospitalier de l'Université de Montréal [CRCHUM], Montréal, QC, Canada. 3. McGill Goodman Research Center, McGill University, Montréal, QC, Canada. 4. Digestive Surgery Department, Centre Hospitalier de l'Université de Montréal [CHUM], Montréal, QC, Canada. 5. Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, CHU Sainte-Justine, Université de Montreal, QC, Canada. 6. Pathology Department, Centre Hospitalier de l'Université de Montréal [CHUM], Montréal, QC, Canada. 7. Broad Institute of MIT and Harvard, Cambridge, MA USA. 8. Department of Microbiology and Immunology, McGill University, Montréal, Qc, Canada. 9. Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.
Abstract
BACKGROUND AND AIMS: Crohn's disease [CD] and ulcerative colitis [UC] are distinct forms of inflammatory bowel disease. Heterogeneity of HLA-DR+SIRPα + mononuclear phagocytes [MNPs], including macrophages [MΦ], monocyte-derived [Mono] cells, and dendritic cells [DCs], was reported in gut tissue but not yet investigated in mesenteric lymph nodes [MLNs] of IBD patients. We here compared the phenotype, function, and molecular profile of HLA-DR+SIRPα + MNPs in CD and UC MLNs. METHODS: Cell distribution, morphology, immune function, and transcriptomic [bulk RNAseq] and high-dimensional protein expression profiles [CyTOF] of HLA-DR+SIRPα + MNPs were examined in MLNs of UC [n = 14], CD [n = 35], and non-IBD [n = 12] patients. RESULTS: Elevated frequencies of CD14+CD64+CD163+ [Mono/MΦ-like] MNPs displaying monocyte/MΦ morphology and phagocytic function were a distinct feature of UC MLNs. In CD, the proportion of CD14-CD64-CD163- [DC-like] cells was augmented relative to Mono/MΦ-like cells; DC-like cells drove naïve T cell proliferation, Th1 polarisation, and Th17 TCM plasticity. Gene expression profile corroborated the nature of DC-like cells, best represented by BTLA, SERPINF, IGJ and, of Mono/MΦ-like cells, defined by CD163, MARCO, MAFB, CD300E, S100A9 expression. CyTOF analysis showed that CD123+ plasmacytoid cells predominated over conventional DCs in DC-like cells. Four CD163+ clusters were revealed in Mono/MΦ-like cells, two of which were enriched in MARCO-CD68dimHLA-DRdim monocyte-like cells and MARCOhiCD68hiHLA-DRhi Mɸ, whose proportion increased in UC relative to CD. CONCLUSIONS: Defining the landscape of MNPs in MLNs provided evidence for expansion of CD163+ Mono/MΦ-like cells in UC only, highlighting a distinction between UC and CD, and thus the potential contribution of monocyte-like cells in driving colitis.
BACKGROUND AND AIMS: Crohn's disease [CD] and ulcerative colitis [UC] are distinct forms of inflammatory bowel disease. Heterogeneity of HLA-DR+SIRPα + mononuclear phagocytes [MNPs], including macrophages [MΦ], monocyte-derived [Mono] cells, and dendritic cells [DCs], was reported in gut tissue but not yet investigated in mesenteric lymph nodes [MLNs] of IBDpatients. We here compared the phenotype, function, and molecular profile of HLA-DR+SIRPα + MNPs in CD and UC MLNs. METHODS: Cell distribution, morphology, immune function, and transcriptomic [bulk RNAseq] and high-dimensional protein expression profiles [CyTOF] of HLA-DR+SIRPα + MNPs were examined in MLNs of UC [n = 14], CD [n = 35], and non-IBD [n = 12] patients. RESULTS: Elevated frequencies of CD14+CD64+CD163+ [Mono/MΦ-like] MNPs displaying monocyte/MΦ morphology and phagocytic function were a distinct feature of UC MLNs. In CD, the proportion of CD14-CD64-CD163- [DC-like] cells was augmented relative to Mono/MΦ-like cells; DC-like cells drove naïve T cell proliferation, Th1 polarisation, and Th17 TCM plasticity. Gene expression profile corroborated the nature of DC-like cells, best represented by BTLA, SERPINF, IGJ and, of Mono/MΦ-like cells, defined by CD163, MARCO, MAFB, CD300E, S100A9 expression. CyTOF analysis showed that CD123+ plasmacytoid cells predominated over conventional DCs in DC-like cells. Four CD163+ clusters were revealed in Mono/MΦ-like cells, two of which were enriched in MARCO-CD68dimHLA-DRdim monocyte-like cells and MARCOhiCD68hiHLA-DRhi Mɸ, whose proportion increased in UC relative to CD. CONCLUSIONS: Defining the landscape of MNPs in MLNs provided evidence for expansion of CD163+ Mono/MΦ-like cells in UC only, highlighting a distinction between UC and CD, and thus the potential contribution of monocyte-like cells in driving colitis.
Authors: Marleen I Verstege; Fiebo J W ten Kate; Susanne M Reinartz; Cornelis M van Drunen; Frederik J M Slors; Willem A Bemelman; Florry A Vyth-Dreese; Anje A te Velde Journal: J Histochem Cytochem Date: 2007-11-26 Impact factor: 2.479
Authors: S W F Milling; C D Jenkins; U Yrlid; V Cerovic; H Edmond; V McDonald; M Nassar; G Macpherson Journal: Mucosal Immunol Date: 2008-10-29 Impact factor: 7.313
Authors: Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen Journal: Science Date: 2017-04-21 Impact factor: 47.728
Authors: Radha Ramesh; Lina Kozhaya; Kelly McKevitt; Ivana M Djuretic; Thaddeus J Carlson; Maria A Quintero; Jacob L McCauley; Maria T Abreu; Derya Unutmaz; Mark S Sundrud Journal: J Exp Med Date: 2014-01-06 Impact factor: 14.307
Authors: C L Scott; C C Bain; P B Wright; D Sichien; K Kotarsky; E K Persson; K Luda; M Guilliams; B N Lambrecht; W W Agace; S Wf Milling; A M Mowat Journal: Mucosal Immunol Date: 2014-08-20 Impact factor: 7.313
Authors: Daria Esterházy; Maria C C Canesso; Luka Mesin; Paul A Muller; Tiago B R de Castro; Ainsley Lockhart; Mahmoud ElJalby; Ana M C Faria; Daniel Mucida Journal: Nature Date: 2019-04-15 Impact factor: 49.962
Authors: Elin Jaensson; Heli Uronen-Hansson; Oliver Pabst; Bertus Eksteen; Jiong Tian; Janine L Coombes; Pia-Lena Berg; Thomas Davidsson; Fiona Powrie; Bengt Johansson-Lindbom; William W Agace Journal: J Exp Med Date: 2008-08-18 Impact factor: 14.307
Authors: B Sensi; L Siragusa; C Efrati; L Petagna; M Franceschilli; V Bellato; A Antonelli; C Arcudi; M Campanelli; S Ingallinella; A M Guida; A Divizia Journal: J Immunol Res Date: 2020-12-26 Impact factor: 4.818
Authors: Dimitrios Nikolakis; Floris A E de Voogd; Maarten J Pruijt; Joep Grootjans; Marleen G van de Sande; Geert R D'Haens Journal: Int J Mol Sci Date: 2022-02-06 Impact factor: 5.923
Authors: Rebecca A Ward; George R Thompson; Alexandra-Chloé Villani; Bo Li; Michael K Mansour; Marcel Wuethrich; Jenny M Tam; Bruce S Klein; Jatin M Vyas Journal: J Fungi (Basel) Date: 2021-05-11